Septic arthritis induced by Streptococcus pneumoniae occurring in rheumatoid arthritis treated with abatacept and

Kazuya Abe1,2, Yuichi Ishikawa1,3,4, Tatsuro Takahashi1

  • 1Department of Rheumatology, Yokohama Rosai Hospital, Yokohama, Kanagawa, Japan.

Insights

Biological disease-modifying antirheumatic drugs (bDMARDs) may increase the risk of pneumococcal septic arthritis in rheumatoid arthritis (RA) patients. Pneumococcal vaccination and careful bDMARD management are recommended for RA patients in remission.

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Rheumatoid arthritis (RA) patients, especially the elderly, are susceptible to septic arthritis, commonly caused by Staphylococcus aureus.
  • Biological disease-modifying antirheumatic drugs (bDMARDs) are frequently used for RA management, but their role in specific infections like pneumococcal septic arthritis remains unclear.
  • Streptococcus pneumoniae (pneumococcus) is a rare but serious cause of septic arthritis.

Observation:

  • A 64-year-old female RA patient treated with bDMARDs (abatacept) and methotrexate, who was in remission and unvaccinated against pneumococcus, developed pneumococcal septic arthritis.
  • The patient presented with left ankle arthralgia and fever, with positive blood and synovial fluid cultures for pneumococcus.
  • Pneumococcal urinary antigen test was also positive, confirming the diagnosis.

Findings:

  • This case report details the first instance of pneumococcal septic arthritis in an RA patient treated with abatacept.
  • The findings suggest a potential risk association between bDMARD use and pneumococcal septic arthritis in RA patients.
  • The patient successfully recovered after antibiotic treatment.

Implications:

  • Encouraging pneumococcal vaccination is crucial for RA patients on bDMARDs.
  • Consideration should be given to spacing or discontinuing bDMARDs in RA patients who have achieved remission to mitigate the risk of severe infections.
  • Further research is warranted to elucidate the precise relationship between bDMARDs and pneumococcal infections in RA.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
31
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
26
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
46
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.0K
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
13